BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 5, 2026
Home
»
Newsletters
» BioWorld
BioWorld
April 17, 2003
View Archived Issues
Primal Publishes GPCR Data, Comes Out Of 'Stealth Mode'
Read More
NimbleGen Completes $12.5M Round For Microarray Business
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
Genzyme Hits EPS Estimates, Reports Delay In Renagel Trial
Genzyme General's first-quarter revenue blossomed nicely and the company hit its earnings-per-share estimates, but the revelation of a data delay from a Renagel trial dropped the company's stock Wednesday. (BioWorld Today)
Read More
GlycoFi Scientists Devise Genetic Combinatorial Library To Develop Humanized Glycosylation Displays
Read More
